C12N 2310/152
On a single-stranded target
Official title: on a single-stranded target, e.g. fold-back TFOs
C12N2310/152 (On a single-stranded target) appears on 42 US grants and 42 published applications in this corpus.
Search patents in C12N- Granted patents
- 42
- Published applications
- 42
- Assignees
- 42
- Inventors
- 109
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 3 |
| 2004 | 0 | 1 |
| 2005 | 0 | 5 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 3 | 0 |
| 2009 | 2 | 4 |
| 2010 | 1 | 0 |
| 2011 | 3 | 4 |
| 2012 | 1 | 1 |
| 2013 | 1 | 0 |
| 2014 | 2 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 4 |
| 2019 | 1 | 0 |
| 2020 | 2 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 4 |
| 2023 | 2 | 1 |
| 2024 | 0 | 3 |
| 2025 | 1 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating sickle cell disease16 Dec 2025US 12,496,357 B2Yale University
- Methods and compositions for modulating gene expression19 Sep 2023US 11,759,533 B2Wisconsin Alumni Research Foundation
- Genome editing using effector oligonucleotides for therapeutic treatment20 Jun 2023US 11,680,265 B2Research Foundation to Cure AIDS, Inc.
- Compositions for enhancing targeted gene editing and methods of use thereof5 Oct 2021US 11,136,597 B2Carnegie Mellon University
- Hybrid oligonucleotides and uses thereof1 Sep 2020US 10,758,558 B2Translate Bio MA, Inc.
- Synthetic triplex peptide nucleic acid-based inhibitors for cancer therapy2 Apr 2026US 2026/0092085 A1Beth Israel Deaconess Medical Center, Inc.
- Compositions and methods for enhancing triplex and nuclease-based gene editing19 Feb 2026US 2026/0048118 A1Yale University
- Genome editing using effector oligonucleotides for therapeutic treatment6 Jun 2024US 2024/0182906 A1Research Foundation to Cure AIDS, Inc.
- Methods and compositions for modulating gene expression28 Mar 2024US 2024/0100191 A1Wisconsin Alumni Research Foundation
- Isolated double stranded dna polynucleotide28 Mar 2024US 2024/0102009 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Methods of making single-stranded circular oligonucleotides178US 5,426,180 AResearch Corporation Technologies, Inc. · 1995
- Compositions and methods for inhibiting expression of anti-apoptotic genes115US 7,423,142 B2Alnylam Pharmaceuticals, Inc. · 2008
- Oligonucleotide clamps having diagnostic applications70US 5,473,060 ALynx Therapeutics, Inc. · 1995
- Triplex-forming antisense oligonucleotides having abasic linkers targeting nucleic acids comprising mixed sequences of purines and pyrimidines66US 5,693,773 AHybridon, Inc. · 1997
- Integrated oligonucleotides63US 5,739,308 AHybridon, Inc. · 1998